Servier throughout the world
THROUGHOUT THE WORLD
Our medicines treat patients in over 150 countries
Our medicines are available in over 150 countries. Pursuing our vocation, we bolster our presence in regions where patient needs are greatest.
Creating value in France and across Europe
Servier has chosen to concentrate on the market in France and Europe to create value through innovation. We have always maintained considerable production capacity, especially at our Oril Industrie facility in Normandy, which produces over 2,000 metric tons of active ingredients each year.
Our Research and Development Institute at Paris-Saclay in France is located at the heart of one of the world’s foremost scientific and technological innovation communities. It bolsters the role we play in establishing European sovereignty and our desire to boost the appeal of research in France.
520
million standard boxes of brand-name medicines were produced worldwide in 2022-2023
96.5%
of active ingredients used in Servier brand-name medicines are produced in France
59%
of the Group’s industrial and R&D investments in 2022-2023 made in France
